SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-415185
Filing Date
2014-11-17
Accepted
2014-11-17 16:27:01
Documents
3
Effectiveness Date
2014-11-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d822746ddfan14a.htm DFAN14A 32037
2 GRAPHIC g822746g46c19.jpg GRAPHIC 8588
3 GRAPHIC g822746g69h72.jpg GRAPHIC 9689
  Complete submission text file 0001193125-14-415185.txt   59290
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-10269 | Film No.: 141228178
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations